This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.
HAYES, Inc.. Use of anti-infliximab antibody levels to monitor infliximab treatment in patients with inflammatory bowel disease (IBD) Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2015
Subject indexing assigned by CRD
Antibodies, Monoclonal; Humans; Inflammatory Bowel Diseases; Infliximab; Monitoring, Physiologic
Country of organisation
An English language summary is available.
Address for correspondence
HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: email@example.com
Date abstract record published